Anthony R. Chase, Director at Sarepta Therapeutics, Inc. (SRPT), sold 10,000 shares at $26.26 ($257K) on 2012-11-14, disclosed to the SEC on 2012-11-15.
Open-market sale of $257k SRPT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.65 | 9,200 | $236K | 91.8% |
| 2 | $26.26 | 800 | $21K | 8.2% |
| Total | $25.70 avg | 10,000 | $257K | 100% |
| Filing → |
| LYB | BUY | 2023-07-10 | $3K | — | Filing → |
| APC | BUY | 2017-05-18 | $200K | — | Filing → |
| APC | BUY | 2014-09-02 | $189K | — | Filing → |